Attenuated response to PPD in the diagnosis of latent tuberculosis infection in patients with rheumatoid arthritis

Revista Brasileira de Reumatologia

Volumn 49, Issue 2, 2009, Pages 121-131

  Marques, Cláudia Diniz Lopes ^a   Duarte, Angela Luzia Branco Pinto ^b   Barros de Lorena, Virgina Maria ^c   de Souza, Joelma Rodrigues ^c   Souza, Wayner ^c   Gomez, Yara de Miranda ^c   de Carvalho, Eduardo Maia Freese ^c  

^a INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Latent tuberculosis; PPD; Rheumatoid arthritis

Indexed keywords

INFLIXIMAB; METHOTREXATE; PREDNISONE; TUBERCULIN; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGED; ARTICLE; BCG VACCINATION; BRAZIL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNE RESPONSE; LATENT TUBERCULOSIS INFECTION; MAJOR CLINICAL STUDY; MALE; PALPATION; RHEUMATOID ARTHRITIS; SKIN INDURATION; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS;

EID: 67651154497     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mangini C, Melo FAF. Artrite reumatoide, terapia imunossupressora e tuberculose. Rev Bras Reumatol 2003;43:XI-XV.
2. Ormerod LP, Milburn HJ, Gillespie S, Ledingham J, Rampton D. British Thoracic Society (BTS) Standards of Care Committee. BTS recommendations for assessing risk and managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment. Thorax 2005;60(10):800-5.
3. Provenzano G, Ferrante MC, Simon G. TB screening and anti-TNF-α treatment. Thorax 2005;60(10):612-5.
4. Panayi G, Corrigal V, Pitzalis C. Pathogenesis of rheumatoid arthritis. The role of cells and others beasts. Rheum Dis Clin North Am 2001;161:221-47.
5. Emery P, Panayi GS, Symmons D, Brown G. Mechanisms of depressed delayed-type hypersensitivity in rheumatoid arthritis: the role of protein energy malnutrition. Ann Rheum Dis 1984;43(3):430-4.
6. Corrigal VM, Garyfallos G, Panayi GS. The relative proportions of secreted interleukin-2 and interleukin-10 determine the magnitude of rheumatoid arthritis T-cell proliferation to the recall antigen tuberculin purified protein derivative. Rheumatology 1999;38:1203-7.
7. Kingsley GH, Pitzalis C, Panayi GS. Abnormal lymphocyte reactivity to self-major histocompatibility antigens in rheumatoid arthritis. J Rheumatol 1987;14(4):667-73.
8. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNF-α Therapy. J Exp Med 2004;200:277-85.
9. + T cells in the blood predicts the in vivo response to PPD. Tuberculosis 2006; 87(3):202-11.
10. Arnett FC, Edworthy SM, Bloch DA, Mcshane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315-24.
11. Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): A review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheum 2005;23(S39):S100-8.
12. Furin JJ, Johnson JL. Recent advances in the diagnosis and management of tuberculosis. Curr Opin Pulm Med 2005;11(3):189-94.
13. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356(9235):1099-104.
14. Ponce de León D, Acevedo-Vazquez E, Sánchez-Torres A, Cucho M, Alfaro J, Perich R et al. Attenuated response to purified protein derivate in patients with rheumatoid artritis: study in a population with high prevalence of tuberculosis. Ann Rheum Dis 2005; 64:1360-1.
15. K⊣soker IH, Pamuk ÖN, Karlikaya N, Tunçbilek N, Cakir N. A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings. Clin Exp Rheumatol 2007;25(1): 54-9.
16. Bahr GM, Sattar MA, Stanford JL, Shaaban MA, Al Shimali B, Siddiqui Z et al. HLA-DR and tuberculin tests in rheumatoid arthritis and tuberculosis. Ann Rheum Dis 1989;48(1):63-8.
17. Dinser R, Fousse M, Sester U, Albrecht K, Singh M, Köhler H et al. Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF-α blocking drugs using a novel flow-cytometric interferon-γ release assay. Rheumatology 2008;47(2):212-218.
18. Dheda K, Udwadia Z, Huggett JF, Johnson MA, Rook GA et al. Utility of the antigen-specific interferon-γ assay for the management of tuberculosis. Curr Opin Pulm Med 2005;11(3):195-202.